D2D Pharma inSIGHTS’ Post

View organization page for D2D Pharma inSIGHTS, graphic

295 followers

🚀 Exciting Developments in the Pharma Industry! 🌟 🔬 The FDA has given the green light to several innovative treatments, including: - Ohtuvayre (ensifentrine) for COPD maintenance. - Tepylute (thiotepa) targeting breast and ovarian cancers. - Capvaxive (pneumococcal 21-valent conjugate vaccine) for pneumococcal disease prevention. - Rytelo (imetelstat) for myelodysplastic syndrome. - Iqirvo (elafibranor for primary biliary cholangitis. 💊 "Sun Pharma" has achieved FDA approval for its new alopecia areata drug, Leqselvi, promising new hope for those affected by this condition. 🌍 Pfizer's gene therapy for hemophilia B has received approval from the European Commission, marking a significant milestone in treatment options available in the EU. 🏥 Despite strong sales reports from major companies like AstraZeneca, Roche, and Sanofi, the EU has controversially rejected Eisai and Biogen's Alzheimer's drug, Leqembi, after approvals in the US and other regions. 🤖 Strategic industry moves: - Caribou Biosciences and Roche have announced strategic shifts, including workforce adjustments. - Vertex Pharmaceuticals has initiated legal action over limits on fertility services for its Casgevy treatment patients. Stay tuned for more updates as the pharma industry continues to innovate and evolve! #Pharma #FDA #Biotech #HealthcareInnovation #MedicalResearch #DrugDevelopment #niper #pharmacy #mpharma #bpharma #Gpat #Niperhyderabad #nipermohali

To view or add a comment, sign in

Explore topics